黑料网

Journal of Cellular and Molecular Pharmacology
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • , Vol 7(3)Vol 7(3): 163
  • DOI: 10.4172/jcmp.1000163

Small Molecule SIRT1 Modulators Using Structure-Based Drug Design for the Treatment of Cancer and Metabolic Diseases

Dmitri Mendeleev*
Institute of Protein Biochemistry, National Research Council, Italy
*Corresponding Author : Dmitri Mendeleev, Institute of Protein Biochemistry, National Research Council, Italy, Email: dmitrim.endeleev78@gmail.com

Received Date: Jun 01, 2023 / Published Date: Jul 28, 2023

Abstract

Exacerbations, which regularly lead to emergency branch visits and hospitalizations, are the most important drivers of morbidity and utilization of fitness care sources amongst sufferers with continual obstructive pulmonary disorder (COPD). Appropriate preference of an effective, long-term pharmacotherapy for decreasing exacerbations is key to COPD management. In this review, we summarize the handy long-acting, upkeep pharmacotherapeutic choices for sufferers with reasonable or extreme COPD and talk about realistic concerns in the administration of these patients. Membrane transporters modify the trafficking of endogenous and exogenous molecules throughout organic obstacles and inside the neurovascular unit. In annoying talent harm (TBI), they average the dynamic motion of therapeutic pills and harm mediators amongst neurons, endothelial cells and glial cells, thereby turning into vital determinants of pathogenesis and nice pharmacotherapy after TBI.

Citation: Mendeleev D (2023) Small Molecule SIRT1 Modulators Using Structure-Based Drug Design for the Treatment of Cancer and Metabolic Diseases. J CellMol Pharmacol 7: 163. Doi: 10.4172/jcmp.1000163

Copyright: © 2023 Mendeleev D. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top